Trump FDA nominee Heidi Overton faces Senate confirmation hurdles

Published Aug 21, 01:00 PM UTC

President Donald Trump's nominee to lead the Food and Drug Administration, Dr. Heidi Overton, faces significant challenges in securing Senate confirmation. Sen. Bill Cassidy, R-La., chairman of the Senate Health, Education, Labor and Pensions Committee, expressed serious doubts about Overton's nomination, citing her lack of managerial experience and her role in a controversial Health and Human Services executive order that would weaken vaccine requirements. Cassidy stated that Overton's involvement in the vaccine order 'calls into question her commitment to standing up for sound science and protecting children's health' and called it 'almost disqualifying.' The White House defended Overton, highlighting her experience as Deputy Assistant to the President for Domestic Policy and her role coordinating interagency policymaking on Trump's MAHA agenda. The confirmation process is uncertain, with Cassidy controlling whether to schedule a hearing or committee vote. The White House has previously had to withdraw other nominees, including surgeon general nominee Dr. Casey Means, when they lacked sufficient votes.